Skip to main content
Premium Trial:

Request an Annual Quote

Two Pore Guys Receive $2.8M TB Dx Grant From Bill & Melinda Gates Foundation

NEW YORK (GenomeWeb) – Californian startup Two Pore Guys said today that it has received a $2.8 million grant from the Bill & Melinda Gates Foundation to develop a sensitive, low-cost molecular diagnostic assay for tuberculosis.

As part of the 18-month grant, the firm will use its solid-state nanopore technology to provide a simple, sensitive, and low-cost point-of-care device that it said would be compatible with automated, wireless reporting for resource-poor areas.

Two Pore Guys' devices use silicon nanopore chips to examine a wide range of individual analytes with high sensitivity. In addition, the firm said its workflows support multiplexed multi-modal assays from a single sample source.

"Our point-of-care technology platform offers tremendous value to address medical testing needs in resource-limited areas," Two Pore Guys Cofounder and interim CEO William Dunbar said in a statement. "We hope to make a difference in the lives of millions of people around the world who need better access to affordable TB care."

The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.